Entry into the Home Healthcare, Nursing Care and Welfare, and Healthcare Businesses
First written in FY2022. 4 of 12 entries say "Advanced", first in FY2023-Q1. Latest entry: 2026-08-07.
1 other company's latest entry also says "Advanced".
- FY2026-H1Shift toward a decline in medical gas piping workAnnual report
「Sales in the Other segment were ¥128 million, a decrease of ¥23 million, or 15.6%, from the previous interim consolidated accounting period, while operating profit was ¥24 million, a decrease of ¥7 million, or 24.0%. In the Other segment, sales and operating profit declined due to a decrease in medical gas piping projects.」
The segment shifted from higher revenue and profit driven by an increase in medical gas piping projects in the previous interim period, with revenue down 15.6% and operating profit down 24.0% due to a decline in projects. - FY2025-H1AdvancedAnnual report
「Sales in the Other segment were ¥152 million, an increase of ¥38 million, or 33.9%, from the previous interim consolidated accounting period, while operating profit was ¥31 million, an increase of ¥10 million, or 48.6%. In the Other segment, sales and operating profit increased due to an increase in medical gas piping projects.」
Large-scale medical gas piping projects, which had declined in the previous fiscal year, increased during the interim period, and the Other segment shifted to higher revenue and profit. - FY2024-Q3RestatedAnnual report
「Sales in the Other segment were ¥176 million, a decrease of ¥51 million, or 22.7%, from the same quarter of the previous year, while operating profit was ¥33 million, a decrease of ¥4 million, or 13.0%. In this segment, sales and operating profit declined due to a decrease in large-scale medical gas piping projects.」
The Other segment, including medical and healthcare-related operations, continues to report lower revenue and profit due to a decline in large-scale medical gas piping projects. - FY2024-Q2RestatedAnnual report
「Sales in the Other segment were ¥114 million, a decrease of ¥51 million, or 31.2%, from the same quarter of the previous year, while operating profit was ¥21 million, a decrease of ¥4 million, or 17.1%. In this segment, sales and operating profit declined due to a decrease in large-scale medical gas piping projects.」
The Other segment, including medical and healthcare-related operations, continues to report lower revenue and profit due to a decline in large-scale medical gas piping projects. - FY2024-Q1RestatedAnnual report
「Sales in the Other segment were ¥56 million, a decrease of ¥23 million, or 29.6%, from the same quarter of the previous year, while operating profit was ¥10 million, a slight decrease of 6.9%. In this segment, sales and operating profit declined due to a decrease in large-scale medical gas piping projects.」
While the previous fiscal year included a statement on increased demand for medical equipment, the Other segment continues to report lower revenue and profit this quarter due to a decline in large-scale medical gas piping projects. - FY2023Higher demand for medical equipment, but lower revenue and profit due to a decline in work in progress on large-scale piping projectsAnnual report
「In this segment, although demand for medical equipment increased, sales and operating profit declined due to a decrease in work in progress on large-scale medical gas piping projects.」
Although demand for medical equipment increased, the Other segment reported lower revenue and profit for the full year due to a decrease in work in progress on large-scale medical gas piping projects. - FY2023-Q3RestatedAnnual report
「Sales in the Other business segment were ¥228 million, an increase of ¥6 million, or 3.0%, from the same quarter of the previous year, while operating profit was ¥38 million, an increase of ¥8 million, or 27.2%. In this segment, sales and operating profit increased due to higher demand for medical equipment.」
The Other business segment continues to report higher revenue and operating profit due to increased demand for medical equipment, and the company continues to disclose performance in the medical and healthcare fields. - FY2023-Q2AdvancedAnnual report
「Sales in the Other business segment were ¥165 million, an increase of ¥24 million, or 17.0%, from the same quarter of the previous year, while operating profit was ¥25 million, an increase of ¥7 million, or 42.5%. In this segment, sales and operating profit increased due to higher demand for medical equipment.」
The Other business segment continued to report higher revenue and operating profit due to increased demand for medical equipment, with further progress in the medical equipment and healthcare fields. - FY2023-Q1AdvancedAnnual report
「Sales in the Other business segment were ¥80 million, an increase of ¥24 million, or 42.3%, from the same quarter of the previous year, while operating profit was ¥11 million, an increase of ¥4 million, or 68.0%. In this segment, sales and operating profit increased due to higher demand for medical equipment.」
The Other business segment reported higher revenue and operating profit due to increased demand for medical equipment, indicating progress in the medical equipment and healthcare fields. - FY2022First statedAnnual report
「We will expand sales channels for various medical gases, including medical oxygen, and medical equipment, and enter the home healthcare, nursing care and welfare, and healthcare businesses.」
In addition to expanding sales channels for medical gases and equipment, the company has, for the first time, explicitly identified entry into home healthcare, nursing care and welfare, and healthcare as growth initiatives.